Companion Animals

Dog Canine IMHA Welfare Management

Immune-mediated hemolytic anemia causes life-threatening destruction of red blood cells in dogs, requiring rapid diagnosis and immunosuppressive treatment.

Key Facts

IMHA causes the immune system to attack and destroy the dog's own red blood cells
Clinical signs include pale gums, lethargy, collapse, and yellow skin in severe hemolysis
Blood transfusion may be required as a bridge to allow immunosuppression to take effect
Prednisolone combined with additional immunosuppressants including mycophenolate treats most cases
Mortality remains 20 to 40 percent despite treatment, often due to thromboembolic complications

Welfare Considerations

Dogs with IMHA experience life-threatening anemia and the systemic effects of severe hemolysis. The acute phase causes extreme debility and distress requiring emergency intervention and intensive monitoring.

What You Can Do

Seek immediate emergency veterinary care for dogs showing sudden weakness and pale gums
Monitor closely for thromboembolic signs during IMHA treatment as directed by your vet
Complete the full immunosuppressive treatment course even after recovery to prevent relapse